E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/19/2005 in the Prospect News PIPE Daily.

New Issue: Tm Bioscience arranges upsized C$9.3 million private placement of shares

By Sheri Kasprzak

Atlanta, Jan. 19 - Tm Bioscience Corp. plans to raise C$9,309,500 in a private placement of shares that was upsized the same day it was announced.

The offering includes 4.33 million shares at C$2.15 each and will be underwritten by a syndicate led by Orion Securities Inc. The other member of the syndicate is Dlouhy Merchant Group Inc.

The offering is expected to close Feb. 3.

The deal was first announced Wednesday as a C$7,525,000 offering of 3.5 million shares but was upsized later in the day.

Tm Bioscience is a Toronto-based genetic testing company. The proceeds from the deal will be used for genetic tests and general working capital.

Issuer:Tm Bioscience Corp.
Issue:Stock
Amount:C$9,309,500
Shares:4.33 million
Price:C$2.15
Warrants:No
Underwriters:Orion Securities Inc. (lead); Dlouhy Merchant Group Inc.
Pricing date:Jan. 19
Settlement date:Feb. 3
Stock price:C$2.16 at close Jan. 19

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.